TORM plc Long Term Incentive Program
Rhea-AI Summary
TORM plc (Nasdaq: A) has adopted a long-term incentive program granting Restricted Share Units (RSUs) to employees and Executive Director Jacob Meldgaard. For 2025, 1,356,087 RSUs will be granted and 255,200 RSUs to Jacob Meldgaard, vesting over three years from 01 January 2027.
Each RSU may be exercised for one TORM A-share at an exercise price of DKK 167.14; theoretical market value of the allocation is USD 10.9m. P&L impact is forecast at USD 6.2m (2026), 3.3m (2027) and 1.4m (2028).
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Sector peers show mixed moves: IDXX up 1.09%, while IQV, MTD, WAT, and LH are down between 0.51% and 2.69%. No peers appeared in the momentum scanner, and sector momentum flags do not indicate a coordinated move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 23 | Conference participation | Neutral | +0.2% | Announcement of fireside chat at TD Cowen’s 46th Annual Health Care Conference. |
| Feb 11 | Dividend declaration | Positive | -3.1% | Quarterly cash dividend of <b>$0.255</b> per share announced for April 22, 2026. |
| Feb 11 | Sustainability award | Positive | -0.1% | Recognition of a partner with the 2025 Instrument Trade‑In Impact Award for waste reduction. |
| Feb 11 | FDA approval | Positive | -0.1% | FDA approval expanding use of PD‑L1 IHC 22C3 pharmDx as a companion diagnostic in EOC. |
| Feb 04 | Product showcase | Positive | +0.6% | Showcase of automated workflow and imaging solutions at SLAS2026 in Boston. |
Recent history shows several instances where positive news (dividends, FDA approval, awards) was followed by flat to negative next-day moves, suggesting investors have not consistently rewarded good news in the short term.
Over recent months, the company highlighted multiple developments, including participation in TD Cowen’s 46th Annual Health Care Conference and showcasing next‑generation automated solutions at SLAS2026. It also announced a quarterly dividend of $0.255 per share and received FDA approval for PD‑L1 IHC 22C3 pharmDx in additional cancer indications. Despite these constructive updates, next‑day price reactions often stayed muted or negative, indicating that investors may already have priced in some of these positives or focused on other factors.
Market Pulse Summary
This announcement outlines a sizeable RSU-based long‑term incentive plan, with 1,356,087 units for participants and 255,200 for the Executive Director, struck at DKK 167.14 per share and valued at USD 10.9m. The program vests over three years and is expected to impact the P&L from 2026 to 2028. Investors may watch future proxy materials, compensation trends, and actual share issuance to assess governance, dilution, and alignment with performance.
Key Terms
volatility financial
AI-generated analysis. Not financial advice.
HELLERUP,
For 2025, the Participants will be granted a total of 1,356,087 RSUs and, subject to vesting, each RSU will entitle the holder to acquire one TORM A-share. The RSUs will vest over a three-year period, with one third of the grant amount vesting at each anniversary during the three-year period starting on 01 January 2027. The exercise price for each TORM A-share is
In addition to the RSUs granted to the Participants, Executive Director Jacob Meldgaard will be granted a total of 255,200 RSUs on similar terms as outlined above.
Holders of the RSUs will have no rights as a shareholder with respect to such RSUs until such time as the RSUs vest, are exercised and TORM A-shares are issued. The RSUs include certain adjustment and acceleration provisions, exercise conditions and other terms customary for restricted stock option programs of this nature.
The theoretical market value of the RSU allocation is calculated at
- The strike price is adjusted for future TORM dividends.
- The volatility of the TORM share is estimated at
40% . - The risk-free interest rate based upon expiry of the RSUs is based on Danish government bonds with maturity corresponding to the maturity of the individual RSUs. The interest rate is between
1.78% -2.01% depending on maturity. - A share price of
DKK 174.35 per A-share at the time of allocation.
The RSU allocation is expected to affect the P&L statement as follows:
USDm | 2026 | 2027 | 2028 | Total |
Effect
| 6.2
| 3.3
| 1.4
| 10.9
|
Contact
Mikael Bo Larsen, Head of Investor Relations
Tel.: +45 5143 8002
About TORM
TORM is one of the world's leading carriers of refined oil products. TORM operates a fleet of product tanker vessels with a strong commitment to safety. environmental responsibility and customer service. TORM was founded in 1889 and conducts business worldwide. TORM's shares are listed on Nasdaq in
Safe Harbor Statement as to the Future
Matters discussed in this release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements reflect our current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are statements other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. Words such as, but not limited to, "expects," "anticipates," "intends," "plans," "believes," "estimates," "targets," "projects," "forecasts," "potential," "continue," "possible," "likely," "may," "could," "should" and similar expressions or phrases may identify forward-looking statements.
The forward-looking statements in this release are based upon various assumptions, many of which are, in turn, based upon further assumptions, including without limitation, management's examination of historical operating trends, data contained in our records and other data available from third parties. Although the Company believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies that are difficult or impossible to predict and are beyond our control, the Company cannot guarantee that it will achieve or accomplish these expectations, beliefs, or projections.
Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to, our future operating or financial results; changes in governmental rules and regulations or actions taken by regulatory authorities; inflationary pressure and central bank policies intended to combat overall inflation and rising interest rates and foreign exchange rates; general domestic and international political conditions or events, including "trade wars" and the war between
In the light of these risks and uncertainties, undue reliance should not be placed on forward-looking statements contained in this release because they are statements about events that are not certain to occur as described or at all. These forward-looking statements are not guarantees of our future performance, and actual results and future developments may vary materially from those projected in the forward-looking statements.
Except to the extent required by applicable law or regulation, the Company undertakes no obligation to release publicly any revisions or updates to these forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events. Please see TORM's filings with the
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/torm-plc/r/torm-plc-long-term-incentive-program,c4313548
The following files are available for download:
03-2026 TORM plc Long Term Incentive Program |
View original content:https://www.prnewswire.com/news-releases/torm-plc-long-term-incentive-program-302698595.html
SOURCE Torm PLC